BACKGROUND: Few data are available on the clinical outcome of patients with acute
coronary syndrome (ACS) complicated by refractory cardiogenic shock or cardiac arrest who …

Background Extracorporeal life support (ECLS) is increasingly used in the treatment of
infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality …

Background In acute myocardial infarction complicated by cardiogenic shock the use of
mechanical circulatory support devices remains controversial and data from randomized …

OBJECTIVES Therapy refractory cardiogenic shock is associated with dismal outcome.
Percutaneous implantation of an extracorporeal life support (ECLS) system achieves …

OBJECTIVES The twin aims of this study were to identify the independent predictors of 30-
day mortality and to analyse the outcomes of patients with cardiogenic shock (CS) …

Aims: The current study presents data from a real-world cohort of patients with refractory
cardiogenic shock (CS) undergoing extracorporeal life support (ECLS) with the aims of …

Background The role of extracorporeal life support (ECLS) in primary cardiogenic shock
(PCS) is well established. In this study, we evaluated the impact of etiology on outcomes …

Up to 10% of patients who arrive at the hospital with acute myocardial infarction (AMI)
present with or develop cardio-genic shock. Some patients, despite inotropes and intra …

Background Treatment with extracorporeal life support (ECLS) in acute myocardial infarction
(AMI) complicated by cardiogenic shock (CS) fell short of improving myocardial recovery …

Purpose Veno-arterial extracorporeal life support (ECLS) is increasingly used in patients
during cardiac arrest and cardiogenic shock, to support both cardiac and pulmonary …